Orlando, Fla.-based LensAR has raised $2.3 million so far among 3 unnamed investors, hoping to hit $19.8 million in equity funding, according to documents filed with the SEC. The fundraising round, launched at the start of the month, isn't independent of any other business transaction, the company noted.
Every year, 15 to 20 people in Switzerland lose a hand in an accident. Provided suitable preconditions are met, a hand transplant is the best treatment method, particularly for patients who have lost both hands. The main problem with this treatment is that patients have to be immunosuppressed...
The ability to measure brain functions non-invasively is important both for clinical diagnoses and research in Neurology and Psychology. Two main imaging techniques are used: positron emission tomography (PET), which reveals metabolic processes in the brain; and activity of different brain regions is measured on the basis of the cells’ oxygen consumption by magnetic resonance imaging (MRI).
Cognitive deficits following ischemic stroke are common and debilitating, even in the relatively few patients who are treated expeditiously so that clots are removed or dissolved rapidly and cerebral blood flow restored. A new study in Restorative Neurology and Neuroscience demonstrates that intracerebral injection of bone-marrow-derived mesenchymal stem cells...
A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
BD, a leading global medical technology company, supports the U.S. Food and Drug Administration's (FDA's) proposed reclassification of rapid influenza detection tests. A hearing, held on June 13th by FDA's CDRH Microbiology Devices Advisory Committee Meeting, examined the FDA's proposal to reclassify rapid influenza detection tests (RIDTs) currently regulated as Class I devices, into Class II devices.
Emotiv, the pioneer developer of Brainwear™, exceeds its $1M Kickstarter stretch goal for the Emotiv Insight, a sleek, 5 channel, wireless headset that reads brain waves and translates them into meaningful data to help track cognitive health. Emotiv's brainwear will be redesigned to also incorporate 6-axis inertial sensors, which will enable additional features including head tracking & motion control.
The FDA has made medical device cybersecurity a high priority, even as it stresses that there have been no reported incidents of malicious medical device hacks or of patients harmed by a security-related issue. But that assurance is based more on assumption than fact, experts say.
Fluke Biomedical is pleased to offer its first Medical Device Quality Assurance Training Summit Sept. 16-20 at the North Seattle Community College (NSCC) Biomed Laboratory in Seattle, Wash. The five-day event is designed for entry-level biomeds / field service technicians and engineers, and will utilize a hands-on approach to understanding medical device risk management, and best practices for safety and performance testing.
Minmax Power announced expansion of their M78A and M78SA switching regulators that are pin-compatible and size-compatible with older and less-efficient LM78xx devices.
LTL Color Compounders has introduced a new product line, ColorFast X Series—a proprietary thermoplastic compounds for extruded sheet, profile and film applications.
Saelig Company has introduced the PP877 Three-Axis Accelerometer, which includes a signal-conditioning interface suitable for any 3-input oscilloscope, but is especially suited to Pico Technology's four-channel PC oscilloscope adapters.
Buck Chuck announced the release of their new 20” ATSC scroll chuck to meet the demand for larger chucking options. This manual, self-centering scroll chuck is designed with a high-quality forged steel body construction to provide precision gripping.
A new test has been developed for medical device manufacturers and biomaterials researchers to screen plastics, composites, and polymers for toxicity. This ZET test utilizes zebrafish (Danio rerio). Zebrafish are extensively used in drug development studies due to their transparent embryos and fast development times.
Kent L. Klaudt, lawyer at the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that U.S. District Court Judge G. Murray Snow of the District of Arizona denied in large part Medtronic’s motion to dismiss a personal injury lawsuit brought by Dr. Cristina Ramirez against the company on grounds that the claims are preempted by Federal law.